2015 Dietary Guidelines Management Team
|
Other
|
ACF, CDC, FDA, HRSA, IHS, OS
|
NCI, NIDDK, OD/ DPCPSI/ ODP
|
1990
|
|
A Pilot Study of Urinary Carcinogen Biomarkers in the Golestan Cohort Study
|
Research Initiative
|
CDC, FDA
|
NCI
|
2015
|
|
Abuse Liability Evaluation for Research, Treatment, and Training (ALERTT)
|
Research Initiative
|
FDA
|
NIDA
|
2011
|
|
Accelerating Medicines Partnership in Rheumatoid Arthritis and Lupus
|
Research Initiative
|
FDA
|
NIAID, NIAMS
|
2014
|
|
Adjuvant Working Group
|
Committee, Advisory Group, or Work Group
|
FDA
|
NCI, NIAID
|
2013
|
|
Advanced Anticonvulsant System Interagency Product Team
|
Committee, Advisory Group, or Work Group
|
FDA, OS
|
NINDS
|
2011
|
|
Advancing Regulatory Science Through Novel Research and Science-Based Technologies
|
Research Initiative
|
FDA
|
NCATS, NIDDK, NINDS, OD/ DPCPSI/ OSC
|
2010
|
|
Adverse Event Reporting and Medical Countermeasures
|
Resource Development
|
FDA
|
NLM
|
2013
|
|
Advisory Committee for Heritable Disorders in Newborn and Children
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, FDA, HRSA
|
NICHD
|
2014
|
|
Advisory Committee for Immunization Practices (ACIP)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NIAID
|
2014
|
|
Aging in Place Workgroup
|
Meeting/ Workshop
|
ACL, CMS, FDA
|
NCATS, NCI, NHLBI, NIA, NIBIB, NINDS, NINR
|
2013
|
|
AIDSinfo/InfoSIDA
|
Resource Development
|
CDC, FDA, HRSA
|
NIAID, NLM, OD/ DPCPSI/ OAR
|
2002
|
|
Alcohol Clinical Trial Initiative (ACTIVE)
|
Committee, Advisory Group, or Work Group
|
FDA
|
NIAAA, NIDA
|
2007
|
|
Alzheimer's Disease Neuroimaging Initiative
|
Research Initiative
|
FDA
|
NIA, NIBIB
|
2004
|
|
American Academy of Pediatrics (AAP) Committee on Drugs
|
Committee, Advisory Group, or Work Group
|
FDA
|
NICHD
|
Unknown
|
|
American Academy of Pediatrics (AAP) Disaster Activity Council, Federal Liaison
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OS
|
NICHD
|
2007
|
|
American Conference for the Treatment of HIV (ACTHIV)
|
Meeting/ Workshop
|
CDC, FDA
|
OD/ DPCPSI/ OAR
|
2005
|
|
Analgesic Clinical Trial Translations, Innovations, Opportunities, and Networks
|
Committee, Advisory Group, or Work Group
|
FDA
|
NCATS, NCI, NIAAA, NIDA, NINDS
|
2011
|
|
Anti-Infective Drugs Advisory Committee
|
Committee, Advisory Group, or Work Group
|
FDA
|
NIAID
|
2007
|
|
Antimicrobial Resistance Challenge Working Group
|
Meeting/ Workshop
|
CDC, FDA, OSG
|
NIAID, OD/ DPCPSI, OD/ OIR/ OTT, OD/ OLPA, OD/ OSP
|
2015
|
|
Antiretroviral Pregnancy Registry
|
Resource Development
|
CDC, FDA, HRSA
|
NICHD
|
1989
|
|
Assay Guidance Manual (AGM) Workshop
|
Meeting/ Workshop
|
FDA
|
NCATS, NCI, NEI, NHGRI, NHLBI, NIAID, NICHD, NIDCR, NIDDK, NIMH, NINR
|
2015
|
|
Assay Guidance Workshop For High Throughput Screening And Lead Discovery
|
Meeting/ Workshop
|
FDA
|
CC, NCATS, NCI, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NICHD, NIDA, NIDCR, NIDDK, NIMH, NIMHD, NINDS
|
2015
|
|
ASTM International F-2529-13--Standard Guide for In-Vivo Evaluation of Osteoinductive Potential for Materials Containing Demineralized Bone (DBM)
|
Research Initiative
|
FDA
|
NIDCR
|
2015
|
|
Autoimmune Diseases Coordinating Committee (ADCC)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, HRSA
|
CSR, FIC, NCATS, NCCIH, NCI, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NINDS, NINR
|
1998
|
|
B-24 Project
|
Research Initiative
|
CDC, FDA
|
NICHD
|
2014
|
|
Behavioral Health Coordinating Council (BHCC) Subcommittee on Marijuana
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, SAMHSA
|
NIDA
|
2014
|
|
Best Pharmaceuticals for Children Act (BPCA) Data Monitoring Committee
|
Committee, Advisory Group, or Work Group
|
FDA
|
NICHD
|
2009
|
|
Best Pharmaceuticals for Children Act Working Group (BPCA)
|
Committee, Advisory Group, or Work Group
|
FDA
|
NICHD
|
Unknown
|
|
Big Data to Knowledge (BD2K)
|
Research Initiative
|
AHRQ, CMS, FDA, OS
|
CC, CIT, CSR, FIC, NCATS, NCCIH, NCI, NCMHD, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM, OD/ DPCPSI, OD/ DPCPSI/ OAR, OD/ DPCPSI/ OBSSR, OD/ DPCPSI/ ODP, OD/ DPCPSI/ ORIP, OD/ DPCPSI/ ORWH, OD/ DPCPSI/ OSC, OD/ OCPL, OD/ OER, OD/ OIR, OD/ OIR/ OTT, OD/ OLPA, OD/ OM/ OB, OD/ OSP
|
2013
|
|
Breastfeeding and Human Lactation Research Scientific Interest Group (BALSIG) Special Interest Group
|
Other
|
FDA, OSG
|
NCI, NICHD, NIDDK, OD/ DPCPSI/ ORWH
|
2013
|
|
Cancer and Women's Health Interagency Agreement
|
Research Initiative
|
FDA
|
NCI
|
2013
|
|
CDC’s Division of Select Agents and Toxins (DSAT)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NIAID
|
2015
|
|
Center for Disease Control (CDC) and Health Resources and Services Administration (HRSA) Advisory Committee on HIV, Viral Hepatitis, and STD Prevention and Treatment (CHACHSPT)
|
Committee, Advisory Group, or Work Group
|
CDC, CMS, FDA, HRSA, IHS, OS, SAMHSA
|
OD/ DPCPSI/ OAR
|
2002
|
|
Characterize Emerging HIV Strains from Blood Donors and Patients
|
Resource Development
|
FDA
|
NIAID
|
2009
|
|
Chemical Integrated Program Team (IPT)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OS
|
NICHD
|
2008
|
|
Chronic Fatigue Syndrome Advisory Committee (CFSAC)
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, CMS, FDA, HRSA, OS
|
CSR, NCATS, NCCIH, NCI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NICHD, NIDCR, NIDDK, NIEHS, NIMH, NINDS, NINR, NLM, OD/ DPCPSI/ OBSSR
|
2003
|
|
Clinical and Translational Research Course for PhD Students
|
Training Initiative
|
FDA
|
CC, NCATS, NCI, NHLBI, NIAID, NIDA, NIDCR, NIDDK, NIGMS, NIMH, NINDS
|
2012
|
|
Clinical Investigator Interagency Working Group for the Development of Antiviral Influenza Therapeutics
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NIAID
|
2009
|
|
Clinical Islet Transplantation Consortium
|
Research Initiative
|
CMS, FDA
|
NIAID, NIDDK
|
2004
|
|
Clinical Trial Designs for Emerging Infectious Diseases
|
Meeting/ Workshop
|
CDC, FDA
|
NIAID
|
2015
|
|
ClinicalTrials.gov
|
Resource Development
|
FDA
|
CC, NCATS, NCCIH, NCI, NCMHD, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM, OD/ OSP
|
2000
|
|
Collaborative Islet Transplant Registry Ad Hoc Scientific Advisory Committee
|
Committee, Advisory Group, or Work Group
|
FDA, HRSA
|
NIAID
|
2009
|
|
Committee on Emerging Science for Environmental Health Decisions
|
Committee, Advisory Group, or Work Group
|
ATSDR, CDC, FDA, OS
|
NCATS, NCI, NHGRI, NICHD, NIEHS
|
2006
|
|
Computational Toxicology for NIH Medications Discovery
|
Research Initiative
|
FDA
|
NIDA
|
2000
|
|
Computer-aided Diagnosis for Radiology Images
|
Research Initiative
|
FDA
|
CC
|
2004
|
|
Conducting Comprehensive Toxicological Assessments
|
Research Initiative
|
FDA
|
NIEHS
|
1996
|
|
Consortium for TB Biomarkers (CTB2)
|
Resource Development
|
FDA
|
NIAID
|
2012
|
|
Countermeasures Against Chemical Threats (CounterACT) Research Network
|
Research Initiative
|
CDC, FDA, OS
|
NEI, NIAID, NIAMS, NICHD, NIEHS, NIGMS, NINDS, NLM
|
2006
|
|
Creutzfeldt-Jakob Disease Surveillance in Recipients of Human Growth Hormone, National Hormone and Pituitary Program (NHPP)
|
Resource Development
|
CDC, FDA
|
NIDDK
|
1985
|
|
DailyMed
|
Resource Development
|
FDA
|
NLM
|
2005
|
|
Demand Reduction Interagency Working Groups
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, HRSA, OS, SAMHSA
|
NIAAA, NIDA
|
2009
|
|
Development and Use of a Non-human Primate Model of Pertussis Diseases and Transmission
|
Research Initiative
|
FDA
|
NIAID
|
2011
|
|
Diabetes Mellitus Interagency Coordinating Committee (DMICC)
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, CMS, FDA, IHS, OS
|
CSR, NCATS, NCCIH, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM
|
1974
|
|
Diet-Induced Hypomethylation in Preneoplastic Liver
|
Research Initiative
|
FDA
|
NCI
|
2004
|
|
Dietary Supplements Ingredient Database (DSID)
|
Research Initiative
|
CDC, FDA
|
NCI, NHLBI, NIDDK, OD/ DPCPSI/ ODP
|
2002
|
|
Dietary Supplements Label Database (DSLD)
|
Resource Development
|
CDC, FDA
|
NLM, OD/ DPCPSI/ ODP
|
2003
|
|
Digital Quantitation of Plasma Cells in Marrow Biopsies
|
Research Initiative
|
FDA
|
CC
|
2011
|
|
Disaster Research Response Project
|
Research Initiative
|
ATSDR, CDC, FDA, OS
|
NIEHS, NLM
|
2013
|
|
Dominantly Inherited Alzheimer's Network (DIAN): International Network for the Identification, Evaluation, and Follow up of Families with Early Onset of Dominantly Inherited Alzheimer's Disease
|
Research Initiative
|
FDA
|
NIA
|
2008
|
|
Drug Induced Liver Injury Network (DILIN)
|
Committee, Advisory Group, or Work Group
|
FDA
|
NIDDK
|
2003
|
|
Ebola Clinical Research Response in West Africa
|
Research Initiative
|
CDC, FDA
|
NIAID
|
2014
|
|
Electronic Research Administration (eRA)
|
Other
|
AHRQ, CDC, FDA, SAMHSA
|
CSR, FIC, NCATS, NCCIH, NCI, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM, OD/ OER
|
2005
|
|
Emergency Care Research Interagency Program Officer Working Group
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, HRSA
|
FIC, NCI, NHLBI, NIA, NIAID, NIAMS, NIBIB, NICHD, NIDDK, NIGMS, NIMH, NINDS, NLM
|
2013
|
|
Endocrinologic and Metabolic Drugs Advisory Committee
|
Committee, Advisory Group, or Work Group
|
FDA
|
NIAID
|
2003
|
|
Enterovirus D68 (EV-D68) Mouse Model Development For Acute Flaccid Myelitis
|
Research Initiative
|
FDA
|
NIAID
|
2015
|
|
European-US Pediatric Formulations Excipients Committee
|
Committee, Advisory Group, or Work Group
|
FDA
|
NICHD
|
2010
|
|
Evaluation of Patient Reported Outcomes Following LASIK Surgery
|
Research Initiative
|
FDA
|
NEI
|
2009
|
|
Extracellular Ribonucleic Acid (RNA) Communication
|
Research Initiative
|
FDA
|
NCATS, OD/ DPCPSI, OD/ DPCPSI/ OSC
|
2013
|
|
Eye Research Collaboration
|
Other
|
FDA
|
NEI
|
2014
|
|
FDA Blood Product Advisory Committee
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
CC, NHLBI
|
2007
|
|
FDA Cancer Imaging Program (CIP) Bi-annual Meeting
|
Meeting/ Workshop
|
FDA
|
NCI
|
2011
|
|
FDA Drug Safety Oversight Board
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, CMS, FDA, HRSA, IHS
|
NCI, OD/ OSP
|
2005
|
|
FDA Medical Countermeasures Initiative (MCMi) Regulatory Science Steering Committee
|
Committee, Advisory Group, or Work Group
|
FDA
|
NIAID
|
2012
|
|
FDA Memorandum of Understanding with NHLBI [Docket No. FDA–2008–N–0043]
|
Committee, Advisory Group, or Work Group
|
FDA
|
NHLBI
|
2008
|
|
FDA Pediatric Advisory Committee (PAC) Neonatal Subcommittee
|
Committee, Advisory Group, or Work Group
|
FDA
|
NICHD
|
2013
|
|
FDA Substance Registry System Public Interface
|
Resource Development
|
FDA
|
NLM
|
2009
|
|
FDA-NCI Every Other Month Meeting
|
Meeting/ Workshop
|
FDA
|
NCI
|
1991
|
|
FDA-NIH Tobacco Regulatory Science Workgroup
|
Research Initiative
|
FDA
|
CSR, FIC, NCI, NEI, NHGRI, NHLBI, NIAAA, NICHD, NIDA, NIDCD, NIDCR, NIEHS, NIGMS, NIMH, NINDS, NINR, NLM, OD/ DPCPSI/ OBSSR
|
2011
|
|
FDA/NIH Interagency Clinical Outcomes Assessments Working Group Meeting
|
Committee, Advisory Group, or Work Group
|
FDA
|
NCCIH, NCI, NHLBI, NIAMS, NIMH, NINDS
|
2013
|
|
Federal Breastfeeding Working Group
|
Committee, Advisory Group, or Work Group
|
ACF, AHRQ, CDC, CMS, FDA, HRSA, IHS, OSG
|
NICHD
|
2009
|
|
Federal Dietary Reference Intakes Steering Committee
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, FDA, OS
|
NIDDK
|
2005
|
|
Federal HIV/AIDS Web Council (AIDS.gov)
|
Resource Development
|
CDC, CMS, FDA, HRSA, IHS, OS, SAMHSA
|
NCI, NIAID, NIDA, NLM, OD/ DPCPSI/ OAR
|
2006
|
|
Federal Interagency Health Equity Team (FIHET)
|
Committee, Advisory Group, or Work Group
|
ACF, ACL, AHRQ, CDC, CMS, FDA, HRSA, IHS, OS, OSG, SAMHSA
|
NCATS, NCI, NHLBI, NIA, NIAAA, NIAID, NICHD, NIDA, NIDCR, NIDDK, NIEHS, NIMH, NIMHD, NINR, OD/ DPCPSI/ ODP
|
2006
|
|
Federal RePORTER
|
Resource Development
|
ACF, AHRQ, CDC, FDA
|
OD/ OER
|
2008
|
|
Federal Supply and Demand of Isotopes
|
Committee, Advisory Group, or Work Group
|
FDA
|
NCI, NIBIB
|
2012
|
|
Federal Working Group on Bone Diseases
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, CMS, FDA, OS
|
CSR, NCATS, NCCIH, NCI, NEI, NIA, NIAAA, NIAMS, NICHD, NIDCR, NIDDK, NIEHS, OD/ DPCPSI/ ORWH
|
1993
|
|
Federal Working Group on Dietary Supplements (FWGoDS)
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, FDA
|
CSR, FIC, NCATS, NCCIH, NCI, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAMS, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM, OD/ DPCPSI/ OBSSR, OD/ DPCPSI/ ODP
|
2005
|
|
FedTel: Cross-Federal work group on telehealth
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, CMS, FDA, HRSA, IHS
|
NIBIB, NLM, OD/ DPCPSI/ OBSSR
|
2011
|
|
Filovirus Animal Non-Clinical Group (FANG)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OS
|
NIAID
|
2011
|
|
Food Safety and Nutrition Working Group
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OS
|
NIDDK, NIEHS
|
2012
|
|
Genetic, Functional, and Epidemiologic Studies of Chronic Hepatitis C
|
Research Initiative
|
FDA
|
NCI
|
2010
|
|
Global Ingredient Archival System (GINAS)
|
Research Initiative
|
FDA
|
NCATS
|
2013
|
|
Health Literacy Work Group
|
Other
|
ACF, AHRQ, CDC, CMS, FDA, HRSA, IHS, OS, OSG
|
NCI, NEI, NHGRI, NHLBI, NICHD, NIDA, NIDCR, NLM
|
2006
|
|
Healthcare Systems (HCS) Research Collaboratory
|
Research Initiative
|
AHRQ, CDC, FDA
|
NCATS, NCCIH, NCI, NHGRI, NHLBI, NIA, NIAMS, NICHD, NIDA, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NINDS, NINR, OD/ DPCPSI/ OSC
|
2011
|
|
Healthy People 2020 - Blood Diseases, Disorders, and Safety
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, HRSA, OS
|
NHLBI
|
2006
|
|
Healthy People 2020 - Kidney Disease
|
Public Education Campaign
|
CDC, CMS, FDA, HRSA, OS
|
NIDDK
|
1998
|
|
Healthy People 2020 - Structured Evidence Queries (SEQs)
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, FDA, HRSA, OS, SAMHSA
|
NLM
|
2009
|
|
Hematopoietic Stem Cell Transplantation Interagency Working Group
|
Committee, Advisory Group, or Work Group
|
FDA, HRSA
|
CC, NCI, NHLBI, NIAID, NIDDK
|
1998
|
|
HHS Action Plan for the Prevention, Care, and Treatment of Viral Hepatitis Interagency Implementation Group (VHIG)
|
Research Initiative
|
AHRQ, CDC, CMS, FDA, HRSA, IHS, SAMHSA
|
NIAID, NIDA, NIDDK, NIMHD
|
2011
|
|
HHS Adolescent Health Working Group
|
Committee, Advisory Group, or Work Group
|
ACF, AHRQ, CDC, CMS, FDA, HRSA, OS, SAMHSA
|
NIAAA, NICHD, NIDA, NIMH
|
2010
|
|
HHS Adult and Adolescent HIV Treatment Guidelines Panel
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, HRSA
|
NICHD
|
Unknown
|
|
HHS Advisory Committee on Blood & Tissue Safety & Availability (ACBTSA)
|
Committee, Advisory Group, or Work Group
|
CDC, CMS, FDA, HRSA, OS
|
CC, NHLBI
|
1997
|
|
HHS ASPR Obstetric-Pediatric and Chemical Integrated Program Teams (IPT)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OS
|
NICHD
|
2008
|
|
HHS Behavioral Health Coordinating Committee (BHCC) Subcommittee on Prescription Drug Abuse
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, CMS, FDA, HRSA, IHS, OS, OSG, SAMHSA
|
NIDA
|
2009
|
|
HHS Biannual Dual Use Research of Concern (DURC) Inventory
|
Resource Development
|
CDC, FDA, OS
|
CC, FIC, NCATS, NCCIH, NCI, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM, OD/ DPCPSI, OD/ OSP
|
2012
|
|
HHS Biomedical Advanced Research and Development Authority (BARDA) Radiological and Nuclear Threats Integrated Program Team
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OS
|
NIAID
|
2007
|
|
HHS Blood, Organ, and Tissue Senior Executive Council (BOTSEC)
|
Committee, Advisory Group, or Work Group
|
CDC, CMS, FDA, OS
|
CC, NHLBI
|
1997
|
|
HHS Dietary Guidance Review Committee
|
Committee, Advisory Group, or Work Group
|
ACF, CDC, FDA, HRSA, IHS, OS
|
NIDDK
|
1990
|
|
HHS Global Health Collaborative
|
Committee, Advisory Group, or Work Group
|
ACF, ACL, AHRQ, ATSDR, CDC, CMS, FDA, HRSA, IHS, OS, OSG, SAMHSA
|
NIMH
|
Unknown
|
|
HHS H5N1 Gain-of-Function Review Group (HHG Review Group)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OS
|
NIAID, OD/ OSP
|
2013
|
|
HHS Initiative on Multiple Chronic Conditions
|
Committee, Advisory Group, or Work Group
|
CDC, CMS, FDA, OS
|
NIA, OD/ DPCPSI/ OBSSR, OD/ OSP
|
2009
|
|
HHS Measurement Policy Council
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, CMS, FDA, HRSA, IHS, SAMHSA
|
NLM
|
2012
|
|
HHS National HIV/AIDS Strategy Implementation Group
|
Committee, Advisory Group, or Work Group
|
ACF, AHRQ, CDC, CMS, FDA, HRSA, IHS, OS, OSG, SAMHSA
|
OD/ DPCPSI/ OAR
|
2009
|
|
HHS Nutrition Policy Board
|
Committee, Advisory Group, or Work Group
|
ACF, CDC, FDA, HRSA, IHS, OS, SAMHSA
|
NIDDK
|
1986
|
|
HHS Secretary's Initiative on Serious Mental Illness (SMI)
|
Committee, Advisory Group, or Work Group
|
ACF, ACL, AHRQ, ATSDR, CDC, CMS, FDA, HRSA, IHS, OS, OSG, SAMHSA
|
NIMH
|
2015
|
|
HHS Tissue and Organ Donor Epidemiology Study (TODES) Working Group
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, HRSA
|
NHLBI
|
2012
|
|
HHS Tobacco Control Implementation Steering Committee
|
Committee, Advisory Group, or Work Group
|
CDC, CMS, FDA, HRSA, SAMHSA
|
NCI, NIDA
|
2011
|
|
HHS Viral Hepatitis Interagency Working Group
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, CMS, FDA, HRSA, IHS, OS, SAMHSA
|
CC, NCCIH, NCI, NHLBI, NIA, NIAAA, NIAID, NICHD, NIDA, NIDDK, NIMHD, OD/ DPCPSI/ OAR
|
2009
|
|
HHS Working Group on the Epilepsies
|
Committee, Advisory Group, or Work Group
|
ACL, CDC, CMS, FDA, HRSA, OS
|
NIA, NICHD, NIMH, NINDS
|
2012
|
|
Human Immunology Project Consortium Collaboration on Mechanism Studies of Influenza Vaccination
|
Research Initiative
|
FDA
|
NIAID
|
2014
|
|
ICARE: Interagency Collaborative to Advance Research in Epilepsy
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, FDA, HRSA, OS
|
FIC, NCATS, NHGRI, NHLBI, NIA, NIAAA, NIAMS, NICHD, NIDA, NIMH, NINDS
|
2003
|
|
Image-guided Interventional Therapeutics
|
Research Initiative
|
FDA
|
CC, NCI
|
2004
|
|
Improving Technical Standards and Molecular Tools for Probiotics Research and Development
|
Research Initiative
|
FDA
|
NCCIH
|
2008
|
|
Influenza Risk Management Meeting
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OS
|
NIAID
|
Unknown
|
|
Influenza Vaccine Manufacturing Improvement Group
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OS
|
NIAID
|
2010
|
|
Institute of Medicine Consensus Study on Accessible and Affordable Hearing Health Care for Adults
|
Meeting/ Workshop
|
CDC, FDA
|
NIA, NIDCD
|
2015
|
|
Interagency Agreement for Communications on Prevention of Underage Tobacco Use
|
Public Education Campaign
|
FDA
|
NCI
|
2012
|
|
Interagency Artificial Pancreas Working Group
|
Committee, Advisory Group, or Work Group
|
FDA
|
NIBIB, NICHD, NIDDK
|
2007
|
|
Interagency Autism Coordinating Committee (IACC)
|
Committee, Advisory Group, or Work Group
|
ACF, ACL, CDC, CMS, FDA, HRSA, SAMHSA
|
NICHD, NIDCD, NIEHS, NIMH, NINDS
|
2000
|
|
Interagency Committee on Disability Research (ICDR)
|
Committee, Advisory Group, or Work Group
|
ACF, AHRQ, ATSDR, CDC, CMS, FDA, HRSA, IHS, OS, OSG, SAMHSA
|
NIDCD
|
1996
|
|
Interagency Coordinating Committee for Newborn Screening
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, FDA, HRSA
|
NICHD
|
2008
|
|
Interagency Coordinating Committee on Human Growth Hormone and Creutzfeldt - Jakob disease
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NICHD, NIDDK, NINDS
|
1985
|
|
Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM)
|
Research Initiative
|
ATSDR, CDC, FDA
|
NCI, NEI, NIAID, NIEHS, NLM
|
2000
|
|
Interagency Dual Use Outreach Working Group (IDOWG)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OS
|
NIAID, OD/ OSP
|
2012
|
|
Interagency Group on Alzheimer's Disease and Related Dementias for implementation of the National Alzheimer's Project Act
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, CMS, FDA, HRSA
|
NIA
|
2011
|
|
Interagency Midazolam Product Coordination Team
|
Committee, Advisory Group, or Work Group
|
FDA, OS
|
NINDS
|
2011
|
|
Interagency Modeling and Analysis Group (IMAG)
|
Committee, Advisory Group, or Work Group
|
FDA
|
CSR, NCI, NHGRI, NHLBI, NIA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDDK, NIEHS, NIGMS, NIMH, NINDS, NLM, OD/ DPCPSI/ OBSSR
|
2003
|
|
Interagency Pain Research Coordinating Committee (IPRCC)
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, FDA
|
NCCIH, NIDA, NIDCR, NINDS, NINR
|
2011
|
|
Interagency Public Access Working Group
|
Other
|
ACL, AHRQ, CDC, FDA, OS
|
OD/ OER, OD/ OSP
|
2013
|
|
Interagency Select Agent Review Group (ISARG)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OS
|
NIAID, OD/ OM/ OB, OD/ OSP
|
Unknown
|
|
Interagency Task Force on Antimicrobial Resistance (ITFAR)
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, CMS, FDA, HRSA, OS
|
NIAID
|
1999
|
|
Interagency Workgroup on Technology to Facilitate Aging in Place
|
Research Initiative
|
ACL, CMS, FDA
|
NCI, NHLBI, NIA, NIBIB, NINDS, NINR
|
2014
|
|
Interagency Working Group on Neuroscience
|
Other
|
CDC, FDA
|
NIA, NIDA, NIMH, NINDS, NINR, OD/ DPCPSI/ OBSSR
|
2012
|
|
INTERMACS - Interagency Registry for Mechanically Assisted Circulatory Support
|
Resource Development
|
CMS, FDA
|
NHLBI
|
2005
|
|
Intradepartmental Council for Native American Affairs (ICNAA)
|
Committee, Advisory Group, or Work Group
|
ACF, ACL, AHRQ, ATSDR, CDC, CMS, FDA, HRSA, IHS, OS, SAMHSA
|
NIMHD
|
2004
|
|
Intragovernmental Select Agents and Toxins Technical Advisory Committee (ISATTAC)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OS
|
NCI, NIAID, OD/ OSP
|
2002
|
|
Joint Committee and Joint Commission Meetings
|
Meeting/ Workshop
|
CDC, FDA, OS
|
FIC, NCI, NIAID
|
2011
|
|
Joint Fellowship Program
|
Training Initiative
|
FDA
|
NCI
|
2005
|
|
Kidney Interagency Coordinating Committee (KICC)
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, CMS, FDA, HRSA, IHS
|
NHLBI, NIA, NIDDK
|
Unknown
|
|
Laboratory-Developed Tests (LDT) Interagency task force
|
Other
|
CDC, CMS, FDA
|
NLM, OD/ OSP
|
2015
|
|
Let's Move/HHS Healthy Weight, Nutrition and Physical Activity Work Group
|
Committee, Advisory Group, or Work Group
|
ACF, AHRQ, CDC, CMS, FDA, HRSA, IHS, OS, SAMHSA
|
NCI, NHLBI, NICHD, NIDDK, OD/ DPCPSI/ ODP
|
2012
|
|
Lupus Federal Working Group
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, FDA, HRSA, OS
|
NCCIH, NEI, NHLBI, NIAID, NIAMS, NICHD, NIDCR, NIDDK, NIEHS, NIMHD, NINDS, OD/ DPCPSI/ OBSSR, OD/ DPCPSI/ ORWH
|
2003
|
|
Lyme and Tick-borne Diseases Work Group
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OS
|
NIAID
|
2011
|
|
Medical Countermeasures Surveillance Integrated Program Team
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OS
|
NIAID
|
2012
|
|
Memorandum of Understanding (MOU) between the FDA Center for Devices and Radiological Health and NIH/NINDS
|
Other
|
FDA
|
NINDS
|
2015
|
|
Memorandum of Understanding (MOU) between the FDA/Center for Biologics Evaluation and Research (FDA/CBER) and NIH/NINDS
|
Other
|
FDA
|
NINDS
|
2002
|
|
Memorandum of Understanding Between National Toxicology Program (NTP) and NIH/NIEHS, FDA, and CDC/NIOSH
|
Other
|
CDC, FDA
|
NIEHS
|
1978
|
|
Microbiological Testing of Live Biotherapeutic Products
|
Resource Development
|
FDA
|
NIAID
|
2015
|
|
Microphysiological Systems for Drug Efficacy and Toxicity Testing
|
Research Initiative
|
FDA
|
NCATS, NCI, NEI, NHLBI, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCR, NIDDK, NIEHS, NIGMS, NINDS, NINR, OD/ DPCPSI, OD/ DPCPSI/ ORWH
|
2012
|
|
Microsystems Team
|
Committee, Advisory Group, or Work Group
|
FDA
|
NIDDK, NINDS
|
2011
|
|
mPOWER mHealth Group
|
Research Initiative
|
CDC, CMS, FDA, HRSA, IHS
|
CIT, FIC, NCCIH, NCI, NEI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NINDS, NINR, NLM, OD/ DPCPSI/ OBSSR
|
2011
|
|
Multi-Agency Tissue Engineering Science (MATES) Interagency Working Group
|
Committee, Advisory Group, or Work Group
|
ACL, CMS, FDA
|
NCI, NHLBI, NIA, NIAMS, NIBIB, NICHD, NIDCD, NIDCR, NINDS
|
2000
|
|
Muscular Dystrophy Coordinating Committee (MDCC)
|
Committee, Advisory Group, or Work Group
|
ACL, CDC, FDA, HRSA
|
NHLBI, NIAMS, NICHD, NINDS
|
2002
|
|
Naloxone Workgroup
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NIDA
|
2011
|
|
Nanomaterial Registry
|
Resource Development
|
CDC, FDA
|
NCI, NIBIB, NIEHS
|
2010
|
|
Nanotechnology Characterization Laboratory
|
Research Initiative
|
FDA
|
NCI, NIEHS
|
2004
|
|
National Asthma Control Initiative (NACI)/National Asthma Education and Prevention Program (NAEPP)
|
Public Education Campaign
|
CDC, FDA
|
NHLBI, NIAID, NIEHS
|
2008
|
|
National Asthma Education and Prevention Program Federal Liaison Group on Asthma (FLGA)
|
Committee, Advisory Group, or Work Group
|
AHRQ, ATSDR, CDC, CMS, FDA, HRSA, OS
|
NHLBI, NIA, NIAID, NICHD, NIEHS, NIMHD, NINR
|
1998
|
|
National Blood Disorders Program
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, CMS, FDA, HRSA, OS
|
NHLBI, NIMHD
|
2011
|
|
National Clinical Trials Network (NCTN) Scientific Steering Committees (SSCs)
|
Committee, Advisory Group, or Work Group
|
FDA
|
NCI
|
2008
|
|
National Coalition for Oversite of Assisted Reproductive Technologies (NCOART)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NICHD
|
1997
|
|
National Food and Nutrient Analysis Program (NFNAP)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, IHS
|
NCI, NEI, NHLBI, NIA, NICHD, NIDDK, OD/ DPCPSI/ ODP, OD/ DPCPSI/ ORWH
|
1997
|
|
National Health and Nutrition Examination Survey (NHANES)
|
Health Survey
|
CDC, FDA, OS
|
NCI, NHLBI, NIA, NIDDK, OD/ DPCPSI/ ODP
|
1999
|
|
National Interagency Confederation for Biological Research
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NCI, NIAID
|
2002
|
|
National Kidney Disease Education Program (NKDEP)
|
Public Education Campaign
|
AHRQ, CDC, CMS, FDA, HRSA, IHS, OS
|
NHLBI, NIDDK
|
1998
|
|
National Nanotechnology Initiative (NNI) Nanotechnology Signature Initiative on Nanotechnology for Sensors and Sensors for Nanotechnology: Improving and Protecting Health, Safety, and the Environment
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NCI, NIBIB
|
2012
|
|
National Nanotechnology Initiative (NNI) Nanotechnology Signature Initiative on Nanotechnology Knowledge Infrastructure: Enabling National Leadership in Sustainable Design
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NCI, NIBIB
|
2012
|
|
National Robotics Initiative
|
Research Initiative
|
FDA
|
NEI, NIA, NIBIB, NICHD, NIDCD, NINDS, NINR, OD/ DPCPSI/ OBSSR
|
2009
|
|
National Science Advisory Board for Biosecurity
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NIAID, OD/ OSP
|
2004
|
|
National Security Staff Combatting Antibiotic-Resistant Bacteria sub-Interagency Policy Committee (NSS CARB sub-IPC)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OS
|
NIAID, NLM, OD/ OSP
|
2014
|
|
National Toxicology Program (NTP) Executive Committee
|
Committee, Advisory Group, or Work Group
|
ATSDR, CDC, FDA
|
NCI, NIEHS
|
1985
|
|
NCI Clinical Trials and Translational Research Advisory Committee (CTAC)
|
Committee, Advisory Group, or Work Group
|
CMS, FDA
|
NCI
|
2007
|
|
NCI National Cancer Informatics Program (NCIP) Nanotechnology Working Group
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NCI, NHLBI, NIBIB, NIEHS
|
2008
|
|
NCI/FDA Federal Investigator Registry of Biomedical Information Research Data (FIREBIRD)
|
Resource Development
|
FDA
|
NCI
|
2004
|
|
NCI/FDA Memorandum of Understanding for Drug Related Information
|
Resource Development
|
FDA
|
NCI
|
2012
|
|
NCI/FDA Memorandum of Understanding for Proteomics
|
Research Initiative
|
FDA
|
NCI
|
2007
|
|
NEI/FDA Symposium – Ocular Inflammatory Diseases
|
Meeting/ Workshop
|
FDA
|
NEI
|
2015
|
|
NEI/FDA Symposium: NEI-FDA Diabetic Retinopathy Clinical Trial Endpoints Symposium
|
Meeting/ Workshop
|
FDA
|
NEI
|
2015
|
|
Neural Interfaces Conference
|
Meeting/ Workshop
|
FDA
|
CSR, NEI, NIA, NIBIB, NICHD, NIDCD, NINDS
|
2006
|
|
Newborn Screening Pompe Pilot Study
|
Research Initiative
|
CDC, FDA, HRSA
|
NICHD
|
2014
|
|
Newborn Screening Quality Improvement Committee
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, HRSA
|
NICHD
|
Unknown
|
|
NHLBI Federal COPD Workshop
|
Committee, Advisory Group, or Work Group
|
ACL, CDC, CMS, FDA, HRSA, IHS
|
NCCIH, NHLBI
|
2013
|
|
Nicotine Research Cigarettes (SPECTRUM)
|
Committee, Advisory Group, or Work Group
|
FDA
|
NIDA
|
2013
|
|
NIH Biomarkers Consortium
|
Research Initiative
|
CMS, FDA
|
NCCIH, NCI, NEI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDDK, NIMH, NINDS
|
2006
|
|
NIH Guide for Grants and Contracts
|
Resource Development
|
AHRQ, CDC, FDA
|
CC, CIT, CSR, FIC, NCATS, NCCIH, NCI, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM, OD/ DPCPSI, OD/ OER
|
2007
|
|
NIH Recombinant DNA Advisory Committee (RAC)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OS
|
NCI, NHGRI, NIAID, NINDS, OD/ OSP
|
1974
|
|
NIH Translational Research Interest Group
|
Committee, Advisory Group, or Work Group
|
FDA
|
CC, CIT, CSR, NCATS, NCCIH, NCI, NCMHD, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM, OD/ DPCPSI, OD/ OER, OD/ OIR, OD/ OSP
|
2008
|
|
NIH-FDA Clinical Trial Protocol Template Workgroup
|
Committee, Advisory Group, or Work Group
|
FDA
|
NCATS, NCI, NIAAA, NIAID, NIAMS, NICHD, NIDA, NIDDK, NIMH, NINDS
|
2015
|
|
NIH-FDA Joint Leadership Council
|
Committee, Advisory Group, or Work Group
|
FDA
|
NCATS, NCCIH, NCI, NHLBI, NIAID, NIDDK, NIMH, NINDS, OD/ OSP
|
2010
|
|
Novel Vaccines and Poliomyelitis Disease
|
Meeting/ Workshop
|
CDC, FDA
|
FIC
|
2014
|
|
Nutrition Coordinating Committee (NCC)
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, FDA, HRSA, IHS, OS
|
CC, CIT, CSR, FIC, NCCIH, NCI, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR
|
1975
|
|
Office of Science and Technology Mo99 Stakeholders Working Group
|
Committee, Advisory Group, or Work Group
|
CMS, FDA, OSG
|
NCI, NIBIB
|
2011
|
|
Oligonucleotide and sequencing services from FDA
|
Research Initiative
|
FDA
|
NICHD
|
2014
|
|
P63, P13K and RAS oncogenes in tumorigenesis, immune deregulation and therapy of squamous cell carcinoma
|
Research Initiative
|
FDA
|
NIDCD
|
2014
|
|
Panel workgroup for updating US Pediatric HIV treatment guidelines
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, HRSA
|
NIAID, NICHD
|
2015
|
|
Pathogen Detection Project
|
Resource Development
|
CDC, FDA
|
NLM
|
2015
|
|
Pathways to Prevention Workshop: The Role of Opioids in the Treatment of Chronic Pain
|
Meeting/ Workshop
|
AHRQ, CDC, FDA, IHS, OS, SAMHSA
|
NCI, NIA, NIDA, NINDS, OD/ DPCPSI/ ODP
|
2012
|
|
Pertussis Working Group
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NIAID
|
2012
|
|
PhenX Tobacco Regulatory Research (TRR) Working Groups
|
Committee, Advisory Group, or Work Group
|
FDA
|
NIDA
|
Unknown
|
|
Pilot Studies Working Group
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, HRSA
|
NICHD
|
Unknown
|
|
Policy and Research Needs to Maximize Independence and Support Community Living-A Workshop
|
Meeting/ Workshop
|
ACL, CMS, FDA
|
NHLBI, NIA
|
2015
|
|
Population Assessment of Tobacco and Health (PATH) Study
|
Health Survey
|
FDA
|
NIDA
|
2011
|
|
Preclinical Assessment of Phage Therapy for Pathogen Decolonization
|
Research Initiative
|
FDA
|
NIAID
|
2015
|
|
Promoting Semantic Interoperability of Laboratory Data Test Results
|
Resource Development
|
CDC, FDA
|
NLM
|
2015
|
|
Public Health and Emergency Medical Countermeasures Enterprise (PHEMCE)
|
Committee, Advisory Group, or Work Group
|
ACF, CDC, FDA, OS, SAMHSA
|
NIAID, NIAMS, NICHD, NINDS, NLM
|
2007
|
|
Public Health Emergency Medical Countermeasures Enterprise (PHEMCE) Chemical Integrated Product Development Team (IPT)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OS
|
NIAID, NINDS
|
2007
|
|
Quantitative Data Mining for Drug-Adverse Event Safety Signal Detection Using MEDLINE
|
Research Initiative
|
FDA
|
NLM
|
2012
|
|
Radiation Biodosimetry Working Group
|
Committee, Advisory Group, or Work Group
|
FDA
|
NIAID
|
2012
|
|
Radiobiology Bioterrorism Research and Training Group (RABRAT)
|
Meeting/ Workshop
|
FDA, OS
|
NCI
|
2003
|
|
Reciprocal Educational and Training Partnerships between FDA/CDER and the NIH Clinical Center
|
Training Initiative
|
FDA
|
CC, NCI, NIAID, NIDCR, NIDDK, NIMH, NINDS
|
2007
|
|
RxNorm
|
Resource Development
|
FDA
|
NLM
|
2005
|
|
Sabbatical in Clinical Research Management Program
|
Training Initiative
|
FDA, OS
|
CC, FIC, NCATS, NEI, NHLBI, NIAID, NIDCR, NIDDK
|
2009
|
|
Sequencing Quality Control (SEQC) Toxicogenomics (TGMX) Study
|
Research Initiative
|
FDA
|
NIEHS
|
2012
|
|
Smoking Cessation Workgroup
|
Committee, Advisory Group, or Work Group
|
CDC, CMS, FDA, HRSA, OS, SAMHSA
|
NCI, NIDA
|
Unknown
|
|
Specialized Centers of Research (SCOR) on Sex and Gender Factors Affecting Women's Health
|
Research Initiative
|
FDA
|
NIAMS, NICHD, NIDA, NIDDK, NIMH, OD/ DPCPSI/ ORWH
|
2002
|
|
Specificity and Quality of Influenza Specific Antibodies
|
Research Initiative
|
FDA
|
NIAID
|
2015
|
|
Standardization of Methods to Generate Spiked Clinical Samples for Use in Studies to Support FDA Clearance of Diagnostics for Low Prevalence Pathogens
|
Research Initiative
|
FDA
|
NIAID
|
2014
|
|
Structured Data Capture (SDC) Initiative
|
Resource Development
|
AHRQ, CDC, CMS, FDA, HRSA, IHS, OS
|
NCI, NLM
|
2013
|
|
Structured Data Capture Forms and Common Data Element Working Groups
|
Other
|
AHRQ, CDC, FDA
|
NCI, NLM
|
2013
|
|
Sub-SPIRIT Ebola Environment Sampling Concept of Operations
|
Committee, Advisory Group, or Work Group
|
FDA, OS, SAMHSA
|
NICHD
|
2014
|
|
Subpopulations and Intermediate Outcome Measures in Chronic Obstructive Pulmonary Disease (COPD)
|
Research Initiative
|
FDA
|
NHLBI
|
2006
|
|
Sudden Unexpected/Unexplained Infant Death (SUID)/Sudden Infant Death Syndrome (SIDS) workgroup
|
Meeting/ Workshop
|
ACF, CDC, FDA, HRSA, IHS
|
NICHD
|
2014
|
|
Support for Implementation of Agency Public Access Policies
|
Resource Development
|
AHRQ, CDC, FDA, OS
|
NLM
|
2013
|
|
Systematized Nomenclature of Medicine-Clinical Terms (SNOMED CT)
|
Resource Development
|
AHRQ, CDC, CMS, FDA, HRSA, IHS, OS, SAMHSA
|
NLM
|
2003
|
|
Targeting of Interleukin-13 Receptor a2 for Treatment of Head and Neck Squamous Cell Carcinoma Induced by Conditional Deletion of TGF-ß and PTEN Signaling
|
Research Initiative
|
FDA
|
NIDCD, NIDCR
|
2010
|
|
Task Force on Environmental Health Risks and Safety Risks to Children: Coordinated Federal Action Plan to Reduce Racial and Ethnic Asthma Disparities
|
Committee, Advisory Group, or Work Group
|
ACF, AHRQ, CDC, CMS, FDA, HRSA, IHS, OS, OSG
|
NCMHD, NHLBI, NIAID, NICHD, NIEHS, NINR
|
2009
|
|
The Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative
|
Research Initiative
|
FDA
|
NCCIH, NIA, NIBIB, NIDA, NIDCD, NIMH, NINDS
|
2014
|
|
The Critical Path Institute (C-Path) International Neonatal Consortia (INC)
|
Committee, Advisory Group, or Work Group
|
FDA
|
NICHD
|
2015
|
|
The Critical Path Institute (C-Path) Global Pediatrics Trials Consortium
|
Committee, Advisory Group, or Work Group
|
FDA
|
NICHD
|
2015
|
|
The Effect of Various Drugs on the Retina
|
Other
|
FDA
|
NEI
|
2014
|
|
The Federal Tuberculosis Task Force
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, FDA, HRSA, IHS, OS
|
NIAID, NICHD
|
1991
|
|
The Impact of Tobacco Use on Oral Health and the Oral Microbiome
|
Research Initiative
|
CDC, FDA
|
NCI
|
2012
|
|
The Interagency Committee on Human Nutrition Research (ICHNR)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NIDDK
|
2013
|
|
The Intersection of Violence and HIV Risk in Women Working Group
|
Committee, Advisory Group, or Work Group
|
ACF, CDC, FDA, HRSA, IHS, OS, SAMHSA
|
OD/ DPCPSI/ OAR
|
2012
|
|
The Nanoscale Science, Engineering, and Technology (NSET) Subcommittee
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NCI, NIBIB, OD/ OSP
|
2001
|
|
The NIH Bone Marrow Stromal Cell Transplantation Center
|
Research Initiative
|
FDA
|
CC, NCI, NHLBI, NIAID, NIAMS, NIBIB, NIDCR, NINDS
|
2009
|
|
The Public Health Service (PHS) Men Who Have Sex With Men (MSM) Working Group
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NHLBI
|
2008
|
|
The Public Health Service (PHS) Review Committee on the Use of Marijuana in Clinical Research
|
Committee, Advisory Group, or Work Group
|
FDA, OS, SAMHSA
|
NCCIH, NIDA, NIMH, NINDS
|
2011
|
|
The Science of Sex and Gender in Human Health
|
Training Initiative
|
FDA
|
OD/ DPCPSI/ ORWH
|
2006
|
|
The U.S. Transfusion-Transmissible Infection Monitoring System (TTIMS) – Blood donation safety monitoring program
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NHLBI
|
2015
|
|
Therapeutics for Rare and Neglected Diseases (TRND)/FDA Working Group
|
Committee, Advisory Group, or Work Group
|
FDA
|
NCATS
|
2009
|
|
Tobacco and Nicotine Research Interest Group (TANRIG)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, SAMHSA
|
NCI, NHGRI, NHLBI, NIAAA, NIAID, NICHD, NIDA, NIEHS, NIMH, NINR, OD/ DPCPSI/ OBSSR
|
2003
|
|
Tobacco Regulatory Science Program (TRSP)
|
Research Initiative
|
FDA
|
CSR, NCI, NHLBI, NIAAA, NICHD, NIDA, NIDCR, NIEHS, OD/ DPCPSI/ ODP, OD/ OER
|
2012
|
|
Tox21 - Memorandum of Understanding on High Throughput Screening, Toxicity Pathway Profiling, and Biological Interpretation of Findings
|
Research Initiative
|
FDA
|
NCATS, NIEHS
|
2010
|
|
Trans-Atlantic Task Force on Antimicrobial Resistance (TATFAR)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OS
|
NIAID
|
2009
|
|
Trans-NIH Plan for HIV-Related Research
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, HRSA, OS
|
CSR, FIC, NCATS, NCCIH, NCI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NICHD, NIDA, NIDCR, NIDDK, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM, OD/ DPCPSI, OD/ DPCPSI/ OAR, OD/ DPCPSI/ ORWH
|
1994
|
|
Treating for Two: Safe Medication Use in Pregnancy Initiative
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, FDA, HRSA
|
NICHD, OD/ DPCPSI/ ORWH
|
2012
|
|
Tularemia Animal Model Qualification Working Group
|
Committee, Advisory Group, or Work Group
|
FDA
|
NIAID
|
2013
|
|
U. S. Government Interagency Working Group on Nanotechnology Environmental, and Health Implications (NEHI), of the Nanoscale Science, Engineering, and Technology Subcommittee (NSET) of the National Science and Technology Council (NSTC)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NCI, NIEHS
|
2005
|
|
U.S.-Uzbekistan Joint Committee Meeting (JCM) for Science & Technology Cooperation
|
Meeting/ Workshop
|
FDA
|
NCI, NIAID
|
2014
|
|
Understanding and Identifying the Needs for Medical Devices
|
Committee, Advisory Group, or Work Group
|
FDA
|
NCATS
|
2014
|
|
Unified Medical Language System Metathesaurus (UMLS)
|
Resource Development
|
AHRQ, CDC, CMS, FDA
|
NLM
|
1990
|
|
Urology Interagency Coordinating Committee
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, CMS, FDA
|
NCCIH, NCI, NIA, NICHD, NIDDK, NINDS
|
Unknown
|
|
US Public Health Service (USPHS) Physicians Professional Advisory Committee (PPAC)
|
Committee, Advisory Group, or Work Group
|
CDC, CMS, FDA
|
NIAID
|
2015
|
|
Viral Hepatitis Implementation Group
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, CMS, FDA, HRSA, IHS, SAMHSA
|
NIDA, NIDDK
|
2014
|
|
Working Groups to Develop Federal HIV/AIDS Prevention and Treatment Guidelines
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, HRSA
|
NICHD, NIMH, OD/ DPCPSI/ OAR
|
1998
|
|
Workshop on Research Directions in Genetically-Mediated Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis
|
Meeting/ Workshop
|
FDA
|
CC, NEI, NHGRI, NIAID, NIDDK, NIGMS, NIMH, NINDS
|
2014
|
|
Yale Specialized Center of Research (SCOR) on Gender-Sensitive Treatment for Tobacco Dependence
|
Research Initiative
|
FDA
|
NIDA
|
2011
|
|
|